Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New surgical trick may fix stubborn eye holes

NCT ID NCT02946372

Disease control Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new surgical technique for macular holes that remained open after standard treatment. The procedure involves moving a thin membrane from the eye to cover the hole. Only 16 people were enrolled, and the study was stopped early, so we don't yet know if this approach is truly effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
internal limiting membrane transplantation (surgical procedure)
What this could lead to
If successful, this technique could offer a new option for people with macular holes that didn't close after standard surgery, potentially improving vision.
What could go wrong
This was a very small pilot study (16 people) that was terminated early, so results are limited. The procedure is still experimental and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

16 people

The number who actually took part.

Start date

Nov 2016

Finished

Jun 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient aged over 18, 2. Patient who already received at least a macular hole surgery, 3. Period of at least 4 months since last macular hole surgery, 4. Patient who underwent peeling of the internal limiting membrane, 5. Presents in OCT an open criteria macular hole, 6. The presence of a cataract in the preoperative clinical examination is not against indication. Its removal can be integrated to the surgery, 7. Patient who signed the consent form Exclusion Criteria: 1. Patient with against-indication or surgical anesthetic, 2. Macular Hole "flat open" or closed, 3. No progressive macular pathology other than the presence of a macular hole (retinal detachment, Macular degeneration related to age) Idiopathic and secondary macular holes are eligible if they have already been operated with the prior internal limiting membrane coat. 4. Patient unaffiliated or not the beneficiary of a social security system, or equivalent health insurance, 5. Pregnant or breastfeeding women, 6. Absence of patient consent, 7. Patient in exclusion period involved in another study, 8. Patient on administrative or judicial supervision

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Macular hole are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

macular holes retinal perforation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Retinal perforations

Contacts and locations

Locations

  • GHRMSA

    Mulhouse, 68100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.